T cell costimulatory receptor CD28 is a primary target for PD-1–mediated 
inhibition

Hui, Enfu; Cheung, Jeanne; Zhu, Jing; Su, Xiaolei; Taylor, Marcus J.; Wallweber, Heidi A.; Sasmal, Dibyendu K.; Huang, Jun; Kim, Jeong M.; Mellman, Ira; Vale, Ronald D.

doi:10.1126/science.aaf1292

アイテム詳細

登録内容を編集ファイル形式で保存

一時保存へ追加

タグ情報を表示リリース履歴を表示詳細要約

公開

学術論文

T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition

MPS-Authors

/persons/resource/persons239172

Taylor, Marcus J.
External Organizations;
Visualisation of Immune Signalling, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource

There are no locators available

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

フルテキスト (公開)

Science_2017_355_1428.pdf
(プレプリント), 2MB

付随資料 (公開)

There is no public supplementary material available

引用

Hui, E., Cheung, J., Zhu, J., Su, X., Taylor, M. J., Wallweber, H. A., Sasmal, D. K., Huang, J., Kim, J. M., Mellman, I., & Vale, R. D. (2017). T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition. Science, 355(6332), 1428-1433. doi:10.1126/science.aaf1292.

引用: https://hdl.handle.net/21.11116/0000-0003-D489-3

要旨

要旨はありません